STOCK TITAN

MDWerks (MDWK) director awarded 150K shares as equity pay

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MDWerks, Inc. (MDWK) reported that director Roy Monroe Milner acquired 150,804 shares of common stock on a grant/award basis at a reported value of $0.07 per share. The award was made quarterly under his February 11, 2026 Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, approved by the board under Rule 16b-3. Following this grant, he holds 297,350 common shares directly.

Positive

  • None.

Negative

  • None.
Insider Milner Roy Monroe
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 150,804 $0.07 $11K
Holdings After Transaction: Common Stock — 297,350 shares (Direct)
Footnotes (1)
  1. F1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.
Shares granted 150,804 shares of Common Stock Grant/award acquisition on August 14, 2026
Grant value per share $0.07 per share Reported transaction price for the 150,804-share grant
Shares owned after transaction 297,350 shares of Common Stock Direct holdings following the August 14, 2026 grant
Equity plan year 2025 Shares issued under the MDWerks, Inc. 2025 Equity Incentive Plan
Employment Agreement date February 11, 2026 Grant made on a quarterly basis pursuant to this agreement
Equity Incentive Plan financial
"issued under the MDWerks, Inc. 2025 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Rule 16b-3 regulatory
"issued in accordance with Rule 16b-3 promulgated under the Securities"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
grant of shares of common stock financial
"Represents the grant of shares of common stock issued on a quarterly"

FAQ

What insider transaction did MDWK report for Roy Monroe Milner?

MDWerks reported that director Roy Monroe Milner received a grant of 150,804 shares of common stock on August 14, 2026, issued as part of his compensation rather than a market purchase.

At what value was the MDWK stock grant to Roy Monroe Milner recorded?

The stock grant to Roy Monroe Milner was recorded at a value of $0.07 per share, according to the Form 4 transaction data for the 150,804 shares of MDWerks common stock.

How many MDWK shares does Roy Monroe Milner own after this transaction?

After the reported grant, Roy Monroe Milner directly owns 297,350 shares of MDWerks, Inc. common stock, as stated in the Form 4 total shares following the transaction field.

What plan and agreement govern the MDWK stock grant to Roy Monroe Milner?

The grant was made on a quarterly basis under Milner’s Employment Agreement dated February 11, 2026 and issued pursuant to the MDWerks, Inc. 2025 Equity Incentive Plan, with approval by the board and in accordance with Rule 16b-3.

Is the MDWK stock grant to Roy Monroe Milner a board-approved compensation award?

Yes. The footnote states the grant of common stock was approved by MDWerks’ board of directors and issued under the company’s 2025 Equity Incentive Plan in accordance with Rule 16b-3 under the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Milner Roy Monroe

(Last)(First)(Middle)
411 WALNUT STREET, SUITE 20125

(Street)
GREEN COVE SPRINGS, FLORIDA 32043

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/14/2026A150,804(1)A$0.07297,350D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.
/s/ Roy Monroe Milner08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)